Literature DB >> 27121885

Proton therapy for nasopharyngeal carcinoma.

Emma B Holliday1, Steven J Frank2.   

Abstract

The treatment of nasopharyngeal carcinoma (NPC) has traditionally included a multimodality approach including radiotherapy (RT) and systemic chemotherapy. RT has long been favored as the mainstay of local treatment for disease in this challenging anatomic location owing to the morbidity of extensive surgical resection in the nasopharynx. However, NPC presents a unique treatment challenge for radiation oncologists because such tumors typically involve complex anatomic structures near several critical organ structures such as the brainstem, spinal cord, temporal lobes, salivary glands, cochleae, oral cavity, mandible and optic structures. Thus, radiation is not without toxicity, and critical organs in these areas clearly benefit from the use of conformal and precise treatment delivery. The unique physical properties of proton radiotherapy (PRT) make it especially well-suited for treating tumors in this anatomically complex area and offer promising potential for acute and chronic toxicity reduction while maintaining excellent disease control.

Entities:  

Keywords:  Nasopharyngeal carcinoma (NPC); intensity-modulated proton therapy (IMPT); proton; radiotherapy (RT); toxicity reduction

Mesh:

Year:  2016        PMID: 27121885     DOI: 10.21037/cco.2016.03.05

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  11 in total

1.  Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy.

Authors:  Quynh Thu Le; A Dimitrios Colevas; Brian O'Sullivan; Anne W M Lee; Nancy Lee; Brigette Ma; Lillian L Siu; John Waldron; Chwee-Ming Lim; Nadeem Riaz; Jean Lynn; Shakun Malik
Journal:  J Natl Cancer Inst       Date:  2019-07-01       Impact factor: 13.506

Review 2.  Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.

Authors:  Danielle L Chappell; Maria C White; Blossom Damania
Journal:  Adv Virus Res       Date:  2020-11-09       Impact factor: 9.937

3.  A Rare Case of Unresectable Adenoid Cystic Carcinoma of the Nasopharynx Treated with Intensity Modulated Proton Therapy.

Authors:  Jae Phan; Sweet Ping Ng; Courtney Pollard; Jack Phan
Journal:  Cureus       Date:  2017-09-15

4.  Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.

Authors:  Jiyi Hu; Cihang Bao; Jing Gao; Xiyin Guan; Weixu Hu; Jing Yang; Chaosu Hu; Lin Kong; Jiade J Lu
Journal:  Cancer       Date:  2018-03-26       Impact factor: 6.860

5.  Characteristic And Novel Therapeutic Strategies Of Nasopharyngeal Carcinoma With Synchronous Metastasis.

Authors:  Wenjun Liao; Maolang Tian; Nianyong Chen
Journal:  Cancer Manag Res       Date:  2019-09-16       Impact factor: 3.989

Review 6.  New frontiers in proton therapy: applications in cancers.

Authors:  Tai-Ze Yuan; Ze-Jiang Zhan; Chao-Nan Qian
Journal:  Cancer Commun (Lond)       Date:  2019-10-22

7.  Potential benefits of adaptive intensity-modulated proton therapy in nasopharyngeal carcinomas.

Authors:  Hideki Minatogawa; Koichi Yasuda; Yasuhiro Dekura; Seishin Takao; Taeko Matsuura; Takaaki Yoshimura; Ryusuke Suzuki; Isao Yokota; Noriyuki Fujima; Rikiya Onimaru; Shinichi Shimizu; Hidefumi Aoyama; Hiroki Shirato
Journal:  J Appl Clin Med Phys       Date:  2020-12-18       Impact factor: 2.102

8.  Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization.

Authors:  Sasidharan Swarnalatha Lucky; Martin Law; Ming Hong Lui; Jamie Mong; Junli Shi; Sidney Yu; Do Kun Yoon; Shih Kien Djeng; Jiguang Wang; Chwee Ming Lim; Min Han Tan
Journal:  Front Oncol       Date:  2021-02-23       Impact factor: 6.244

9.  Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.

Authors:  Fei Ma; Xia Gu; Jiang-Qi Liu; Li-Hua Mo; Gui Yang; Xiao-Rui Geng; Zhi-Qiang Liu; Zhi-Gang Liu; Ping-Chang Yang
Journal:  PLoS One       Date:  2020-03-02       Impact factor: 3.240

10.  Gene expression profile of THZ1-treated nasopharyngeal carcinoma cell lines indicates its involvement in the inhibition of the cell cycle.

Authors:  Lijuan Gao; Shuang Xia; Kunyi Zhang; Chengguang Lin; Xuyu He; Ying Zhang
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.